Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › CBIO

SPHERA FUNDS MANAGEMENT LTD. position in CBIO

CRESCENT BIOPHARMA INC. · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 279,718 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.63% of its reported portfolio and ranking #48 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. first reported this position in Q3 2026.

Latest position (Q3 2026)279.72K sh
Reported value held$4.08M
Portfolio Weight0.63%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s CBIO position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in CBIO in Q3 2026 at 279,718 shares (US$4.1M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 279.72K $4.08M New

About CBIO and 13F data

CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 66 other funds we track also report a position in CBIO — the largest reported positions include Fairmount Funds Management LLC (US$52.5M), BVF INC/IL (US$45.1M), Vestal Point Capital, LP (US$43.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CBIO

All CBIO fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held CBIO?

SPHERA FUNDS MANAGEMENT LTD. has disclosed CBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in CBIO?

As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 279.72K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $4.08M, representing 0.63% of its reported portfolio and ranking #48.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling CBIO?

In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. newly opened its position in CBIO.

Which other funds hold CBIO?

Other major institutional holders of CBIO include Fairmount Funds Management LLC, BVF INC/IL, Vestal Point Capital, LP, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.